Nivolumab-relatlimab for untreated unresectable or metastatic melanoma [ID1688]: A Single Technology Appraisal.


Bresnahan, Rebecca ORCID: 0000-0001-5578-1535, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Bryning, Sam, Nevitt, Sarah, Mahon, James, Beale, Sophie, Boland, Angela, Dundar, Yenal, Marsden, Ashley et al (show 1 more authors) (2024) Nivolumab-relatlimab for untreated unresectable or metastatic melanoma [ID1688]: A Single Technology Appraisal. [Report]

Access the full-text of this item by clicking on the Open Access link.
Item Type: Report
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Population Health
Faculty of Health & Life Sciences > Inst. Population Health > Health Data Science
Depositing User: Symplectic Admin
Date Deposited: 13 Nov 2025 10:58
Last Modified: 13 Nov 2025 10:58
Open Access URL: https://www.nice.org.uk/guidance/ta950/documents/c...
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3195358
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.
CORE (COnnecting REpositories)